top of page
Intravitreal Bevacizumab in Retinopathy of Prematurity: 30 Months Follow-Up. Will we Change our Way of Treating ROP?
bottom of page
Intravitreal Bevacizumab in Retinopathy of Prematurity: 30 Months Follow-Up. Will we Change our Way of Treating ROP?